2023 Volume 49 Issue 1 Pages 21-26
The RECELL® Autologous Skin Cell Harvesting Device generates an autologous skin cell suspension that induces rapid epidermal regeneration and re-epithelialization. The autologous skin cell suspension exhibited comparable results to standard skin grafting as a new treatment for burns with an effective treatment area expansion ratio of up to 80: 1, using significantly less donor skin.
A 1-year-old girl who had scaled burns of 15% total body surface area, primarily to the anterior chest and abdomen, was treated using split-thickness skin grafting and autologous skin cell suspension on the 26th day after the injury. The area of skin that could be harvested was reduced by 32% compared to standard skin grafting. The burn wound was epithelialized on the 6th day postoperatively. Epithelialization was completed 4 days later using autologous skin cell suspension as a donor site.
In pediatric burns, autologous skin cell suspension can close wounds using less donor skin area than standard skin grafting and decreases the epithelialization time required for skin harvested wounds.
